SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Leap Therapeutics Q3 EPS $(0.33) Up From $(0.55) YoY

Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.33) per share. This is a 40 percent increase over losses of $(0.55) per share from the same period last year.

Benzinga · -

Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.33) per share. This is a 40 percent increase over losses of $(0.55) per share from the same period last year.